Helix Pharma

Anticancer

CYTOMIB

CYTOMIB IS INDICATED FOR THE TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA AND ALSO  PATIENTS WITH MANTLE CELL LYMPHOMA.

Overview

Always consult your physician before taking any medicine.

This general information is not intended to diagnose any medical condition or to replace your healthcare professional. Consult with your healthcare professional to adopt an appropriate prescription.

 

Details

Generic Name

BORTEZOMIB

Strength

3.5 MG Injection.

Dosage Form

Injection.

Reviews

There are no reviews yet.

Be the first to review “CYTOMIB”

Your email address will not be published.